|
|
Article: Interleukin Genetics Announces Management Changes.
- Article from:
- Business Wire
- Article date:
- December 16, 2003
CopyrightCOPYRIGHT 2003 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Health/Medical Writers
BIOWIRE2K
WALTHAM, Mass.--(BUSINESS WIRE)--Dec. 16, 2003
Interleukin Genetics, Inc. (OTCBB: ILGN), a leader in the development of DNA testing products to help identify risk for diseases in which inflammation plays a key role, today reported the following management changes:
Fenel M. Eloi, the Company's Chief Operating Officer and Chief Financial Officer has signed a multi-year employment agreement and will continue in his role of providing financial leadership as well as overseeing business development, market development and Clinical Laboratory Operations.
The Company also announced ...